Current treatments for AD, such as acetylcholinesterase inhibitors (e.g., donepezil) and NMDA receptor antagonists (e.g., memantine), provide symptomatic relief but do not halt or reverse disease progression. The gene discussed is ACHE; the disease is Alzheimer disease.